Sodium Oxybate for Postoperative Sleep Disturbance After Thoracic Surgery
Sponsor: Jingsheng Lou • ClinicalTrials.gov ID: NCT07794982
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This is a single-center, randomized, double-blind, placebo-controlled trial. Three hundred-sixty adult patients undergoing elective thoracoscopic surgery will be randomly allocated at a 1:1 ratio to receive either intraoperative sodium oxybate or placebo. The primary objective is to compare postoperative sleep quality between the two groups. Secondary outcomes include postoperative pain scores, incidence of adverse events and other peri-operative indicators.
Interventions
-
sodium oxybate
(Drug)
Intravenous administration during general anesthesia
-
Placebo
(Drug)
Intravenous administration during general anesthesia
Eligibility criteria
Conditions
Locations
- Chinese PLA General Hospital — Beijing, China
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record